Return To Mondaq Homepage Food, Drugs, Healthcare, Life Sciences
Preview most recent added content
Login
Register for Free
First Time Here?
 
Mondaq Topics
 
Our Services
 
About This Site
 
Advertise with Us
Unsubscribe
Copyright
Welcome to Canada
Home Page About Search Canada Browse Site
Your first time here? Click here for a quick guide to our website.

Here you will find the latest thinking on legal, accounting, regulatory and commercial issues supplied by the world's leading professional advisors.

If you are a professional advisor yourself (for example you are part of a law firm, consultancy group or accountancy firm), and your organisation writes articles, please click here.

Below are the latest articles on Food, Drugs, Healthcare, Life Sciences from Canada Briefing. Different topic options are on the left; different regional options are at the top of the page. Alternatively you can search our database for articles by date, topic, firm, country, author, free text, etc.

You are currently viewing content on this site filtered by the topic of Food, Drugs, Healthcare, Life Sciences. If you would like to remove this filter, click here

Free Personalized News Alerts
Keep up to date with the most recently added articles to Mondaq in accordance with your topic preferences.
>Signup<
Latest Video Content
Canada: Generic Damages In Life Sciences Patent Litigation: Strategic Considerations (Video Content)
Canada: A Fundamental Shift In Approach To Health Claims For Foods - Canada Part 3 Conference Video
Canada: Methods Of Medical Treatment Claims Issues In Canada, US And Europe
Hot Topics Headlines

Top 10 Food, Drugs, Healthcare, Life Sciences Headlines from Canada

On April 26, 2013, Health Canada published a notice to inform clinical trial sponsors that information about Clinical Trial Applications ("CTAs") will be published.
The most thought-provoking book I read during my winter vacation this year was Salt Sugar Fat: How the Food Giants Hooked Us by Michael Moss.
In the recent decision, the British Columbia Court of Appeal addressed the issue of liability on the part of a Canadian government regulator for damages arising out of negligent performance of its duties where the performance of those duties led to a recall of the plaintiff's product.
On May 1, 2013, the United States Trade Representative ("USTR") released its annual IP report for 2013.
On April 30, 2013, Justice Zinn of the Federal Court set aside a decision of the PMPRB (the "Board"), which ordered (Order, Reasons) Teva to pay the government $2,801,285 for having sold COPAXONE Syringes (glatiramer acetate) at an "excessive price" between 2004 and 2010
A discussion on the importance of obtaining the effective patent protection for inventions related to stem cells.
After a decade-long battle, Health Canada has announced its intention to get out of the business of supplying medicinal marijuana to Canadians.
Bringing a new drug to market is a costly and time-consuming endeavour.
A number of discussion relating to manufacturing, sales and distribution law.
Latest News
Our most popular article this week:
Salt, Sugar, Fat: Food For Thought
from Food, Drugs, Healthcare, Life Sciences in Canada
by Gowling Lafleur Henderson LLP
View Recent Headlines Covering    
© Mondaq® 1994-2013.
All Rights Reserved